Category: News

Conditions like dementia and Alzheimer’s disease have the most likelihood of a medical breakthrough in the next 10 years. However, at present, there are few effective treatment options. For ASX-listed Neuroscientific Biopharmaceuticals (NSB), this is a focus area that shows great commercial promise and opportunity to improve patient outcomes.

The market’s recent gains have come largely from retail investors entering the market but not everyone is convinced that this rally is real. Magellan Co-founder defended his 46% cash position this week and many others are publicly voicing concerns that the market rally is just a dead cat bounce.

Cancer treatments are changing and Prescient Therapeutics (ASX: PTX) is an Australian biotech company that is leading the way. Prescient’s PTX 100 and PTX 200 therapies have had compelling results in human clinical trials.  

DXN Limited (DXN) is an Australian small cap listed data centre company that is accelerating the shift to edge computing. Any information you access on the Internet goes through a data centre somewhere in the world. In the past decade or so, most data has been stored on cloud-based servers in dispersed locations.

John Rayment, the CEO of Identitii (ID8: ASX), sat down with us last week for a special live investor briefing. He provided an update on the company, how the company can assist with the inaccuracies of information needed to process and report on financial transactions when incomplete or even missing, and why he believes Identitii is a good investment.

From Netflix’s database to every file on the cloud, most data is stored in warehouse-sized data centres owned by tech giants like Google and Amazon. While these warehouse-sized data centres might cater just fine to the casual Internet user’s needs, they can’t offer the high speed and reliability that businesses need to successfully automate and control critical infrastructure.

PayGroup is a payroll and human management SaaS company that simplifies payroll for companies dealing with complicated legislation.

The rallying market has made a 30% comeback since the March 23 lows. Magellan, a global investment firm, is cautious. With so much elevated uncertainty in the market, they’re staying cashed up at 15%, the same level as March.  

LBT Innovations is an Australian company that creates efficiencies in pathology lab processes with artificial intelligence and automation.

Three hundred years ago, Adam Smith emphasised the importance of competition arguing that the “invisible hand”- the natural driving forces of an economy such as competition, should be left to control the market.

ASX listed biotech company Prescient Therapeutics (ASX: PTX) has this week unveiled two significant licence agreements that forms the IP backbone of its work into a universal immune receptor technology platform in the up-and-coming field of CAR-T.

COVID-19 has put many SMEs under existential threat. In reaction to the current climate, some lenders have seen 2000% rise in SME loan applications. SMEs need to access loans quickly and easily. Can traditional lenders’ cumbersome loan processes keep up with the demanding times? Or will SMEs look elsewhere?